Informaciones
Psiquiátricas
2015 - n.º 220
53
COMORBILIDAD MÉDICA Y CRITERIOS DE USO DE ANTIPSICÓTICOS EN ANCIANOS
wide registry study. J Clin Psychiatry.
2013 Sep;74(9):918-24. doi: 10.4088/
JCP.12m08117.
41. Guenette MD, Chintoh A, Remington G,
Hahn M. Atypical antipsychotic-induced
metabolic disturbances in the elderly.
Drugs Aging. 2014 Mar;31(3):159-84.
doi: 10.1007/s40266-014-0152-x. Re-
view.
42. Atti AR, Ferrari Gozzi B, Zuliani G, Ber-
nabei V, Scudellari P, Berardi D, et al.
A systematic review of metabolic side
effects related to the use of antipsycho-
tic drugs in dementia. Int Psychogeriatr.
2014 Jan;26(1):19-37. doi: 10.1017/
S1041610213001658. Epub 2013 Oct 9.
Review.
43. Vasilyeva I, Biscontri RG, Enns MW, Met-
ge CJ, Alessi-Severini S. Movement disor-
ders in elderly users of risperidone and
first generation antipsychotic agents: a
Canadian population-based study. PLoS
One. 2013 May 16;8(5):e64217. doi:
10.1371/journal.pone.0064217. Print
2013.
44. Kalisch Ellett LM, Pratt NL, Ramsay EN,
Barratt JD, Roughead EE. Multiple an-
ticholinergic medication use and risk
of hospital admission for confusion
or dementia. J Am Geriatr Soc. 2014
Oct;62(10):1916-22. doi: 10.1111/
jgs.13054. Epub 2014 Oct 3.
45. Yoon HJ, Park KM, Choi WJ, Choi SH,
Park JY, Kim JJ, et al. Efficacy and safe-
ty of haloperidol versus atypical antip-
sychotic medications in the treatment
of delirium. BMC Psychiatry. 2013 Sep
30;13:240.
46. Straker DA, Shapiro PA, Muskin PR.
Aripiprazole in the treatment of de-
lirium. Psychosomatics. 2006 Sep-
Oct;47(5):385-91.
47. Teslyar P, Stock VM, Wilk CM, Camsari U,
Ehrenreich MJ, Himelhoch S. Prophylaxis
with antipsychotic medication reduces
the risk of post-operative delirium in el-
derly patients: a meta-analysis. Psycho-
somatics. 2013 Mar-Apr;54(2):124-31.
doi: 10.1016/j.psym.2012.12.004. Epub
2013 Feb 4. Review.
48. Gilmore ML, Wolfe DJ. Antipsychotic
prophylaxis in surgical patients mo-
destly decreases delirium incidence--but
not duration--in high-incidence sam-
ples: a meta-analysis. Gen Hosp Psy-
chiatry. 2013 Jul-Aug;35(4):370-5. doi:
10.1016/j.genhosppsych.2012.12.009.
Epub 2013 Jan 23.
49. Mishara AL, Goldberg TE. A meta- analy-
sis and critical review of effects of
conventional neuroleptic treatment on
cognition in schizophrenia: opening a
closed book. Biol Psychiatry. 2004 May
15;55(10):1013-1022.
50. Friedman JH, Berman RM, Goetz CG, Fac-
tor SA, Ondo WG, Wojcieszek J, et al.
Open-label flexible-dose pilot study to
evaluate the safety and tolerability of
aripiprazole in patients with psychosis
associated with Parkinson’s disease.
Mov Disord. 2006 Dec;21(12):2078-81.
51. Rigler SK, Shireman TI, Cook-Wiens
GJ, Ellerbeck EF, Whittle JC, Mehr DR,
Mahnken JD. Fracture risk in nursing
home residents initiating antipsy-
chotic medications. J Am Geriatr Soc.
